ArticleBMJ open2026
Baseline and longitudinal measures of continuity of primary care and COPD-related service utilisation: a cohort study using Korean National Health Insurance Service claims data.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo compare baseline, cluster-based and trajectory-based classifications of continuity of primary care (COC) and to examine their associations with chronic obstructive pulmonary disease (COPD)-related hospitalisation and emergency department (ED) visits.
designPopulation-based retrospective cohort study.
settingNational Health Insurance claims data from South Korea (Korean National Health Insurance Service), 2014-2021.
participants92 977 patients aged ≥40 years newly diagnosed with COPD between 2015 and 2016, with at least four ambulatory primary care visits during the exposure period. PRIMARY AND SECONDARY OUTCOME MEASURES: The primary outcome was the incidence of COPD-related hospitalisation; the secondary outcome was the incidence of COPD-related ED visits. Continuity of primary care was quantified using the Continuity of Care Index (COCI) and classified using three approaches: (1) a baseline COCI-based method, (2) a cluster-based method using K-means clustering and (3) a trajectory-based method using group-based trajectory modelling. Fine-Gray subdistribution hazard models, accounting for death as a competing risk, were used to estimate adjusted HRs (aHRs).
resultsAcross all three classification approaches, low continuity of care was consistently associated with an increased risk of COPD-related hospitalisation (aHR 2.43, 95% CI 2.22 to 2.66 for baseline COCI; 2.26, 95% CI 2.06 to 2.47 for cluster-based; 2.73, 95% CI 2.49 to 2.99 for trajectory-based) and ED visits (aHR 2.32, 95% CI 2.04 to 2.63 for baseline COCI; 2.55, 95% CI 2.25 to 2.88 for cluster-based; 3.48, 95% CI 3.05 to 3.96 for trajectory-based). Effect estimates were consistently strongest for the trajectory-based approach and weakest for the baseline COCI approach. Agreement among the three classification methods was substantial (overall 87.2%; Fleiss' kappa 0.78).
conclusionsBaseline COCI classification offers a pragmatic and robust measure of COC, producing effect estimates directionally consistent with those derived from more complex longitudinal approaches; however, observed transitions between continuity groups over time indicate that reliance on baseline classification alone may attenuate effect estimates when continuity patterns change. Trajectory-based methods may yield additional insight in populations with greater temporal variability in care patterns but entail substantially higher data and modelling requirements.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.